Primary tumor genotype is an important determinant in identification of lung cancer propagating cells - PubMed (original) (raw)
Primary tumor genotype is an important determinant in identification of lung cancer propagating cells
Stephen J Curtis et al. Cell Stem Cell. 2010.
Abstract
Successful cancer therapy requires the elimination or incapacitation of all tumor cells capable of regenerating a tumor. Therapeutic advances therefore necessitate the characterization of the cells that are able to propagate a tumor in vivo. We show an important link between tumor genotype and isolation of tumor-propagating cells (TPCs). Three mouse models of the most common form of human lung cancer each had TPCs with a unique cell-surface phenotype. The cell-surface marker Sca1 did not enrich for TPCs in tumors initiated with oncogenic Kras, and only Sca1-negative cells propagated EGFR mutant tumors. In contrast, Sca1-positive cells were enriched for tumor-propagating activity in Kras tumors with p53 deficiency. Primary tumors that differ in genotype at just one locus can therefore have tumor-propagating cell populations with distinct markers. Our studies show that the genotype of tumor samples must be considered in studies to identify, characterize, and target tumor-propagating cells.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Figures
Figure 1
Orthotopic transplantation of Kras and Kras;p53-flox tumor cells recapitulates the primary tumor phenotype. (A) Cartoon of the transplantation scheme used to assay lung tumor-propagating cells (TPCs) through serial transplantation. (B) H&E staining of primary (left) and secondary (right) Kras lung adenocarcinomas showing similar pathological grade, nuclear features, and general tumor architecture. (C) H&E staining of primary (left) and secondary (right) Kras;p53-flox lung tumors showing similar histopathological characteristics of advanced adenocarcinoma, including pleomorphic nuclei and rare giant cells. All images, 200× magnification. Scale bar = 100μM.
Figure 2
Sca1 + cells from Kras;p53-flox tumors are lung tumor-propagating cells. (A) Representative FACS analysis of Kras;p53-flox tumor cells used for transplantation (top). Limiting dilution transplantation of the sorted cells indicated that the Sca1 + population was significantly enriched for TPCs (table). (B) Sca1- cell transplants yielded smaller, more diffuse lesions (left), whereas Sca1 + cell transplants yielded secondary tumors that recapitulated the histopathology of primary Kras;p53-flox tumors (right, compare to Figure 1C). (C) Immunofluorescence (IF) staining with antisera raised against SP-C (red), CCSP (green), and counterstain DAPI (blue) showed that primary Kras;p53-flox lung adenocarcinomas (left) are mainly composed of SP-C+ cells, a pattern recapitulated in secondary tumors from Sca1 + cell transplants (right). (D) Serial transplantation of secondary tumor cell populations revealed a lack of tumor formation from Sca1 - cells (left), in contrast to tertiary tumor development from Sca1 + cells (right). All images, 200× magnification. Scale bar = 100μM. See also Figure S1 and Table S1 for additional data.
Figure 3
The Sca1 + and Sca1- populations from Kras lung tumors are equally capable of propagating tumors. (A) Representative FACS analysis of Kras tumors showing a pattern of Sca1 staining similar to Kras;p53-flox tumors (top, compare to Figure 2A). Limiting dilution transplantation indicated that Sca1+ and Sca1- Kras tumor cells are identical in tumor-propagating potential (table). (B) Secondary tumors from Sca1- (left) and Sca1+ (right) Kras tumor cell transplants displayed similar pathological features. (C) IF analysis of secondary tumors (as in Figure 2) revealed similar SP-C and CCSP marker status in secondary tumors from Sca1- cells (left) and Sca1+ cells (right). (D) Both Sca1- Kras tumor cells (left) and Sca1+ tumor cells (right) were capable of serial transplantation to form tertiary tumors. All images, 200× magnification. Scale bar = 100μM. See also Figure S2 and Table S2 for additional data.
Comment in
- Tumor oncogenotypes and lung cancer stem cell identity.
Sullivan JP, Minna JD. Sullivan JP, et al. Cell Stem Cell. 2010 Jul 2;7(1):2-4. doi: 10.1016/j.stem.2010.06.005. Cell Stem Cell. 2010. PMID: 20621039 Free PMC article.
References
- Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature medicine. 1997;3:730–737. - PubMed
- Cho RW, Wang X, Diehn M, Shedden K, Chen GY, Sherlock G, Gurney A, Lewicki J, Clarke MF. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells. 2008;26:364–371. - PubMed
Publication types
MeSH terms
Grants and funding
- K08 AG024004/AG/NIA NIH HHS/United States
- P50 CA090578-060009/CA/NCI NIH HHS/United States
- P50 CA090578-060012/CA/NCI NIH HHS/United States
- R01 HL090136-03/HL/NHLBI NIH HHS/United States
- R01 CA122794/CA/NCI NIH HHS/United States
- R01 AG2400401/AG/NIA NIH HHS/United States
- R01 CA140594-01/CA/NCI NIH HHS/United States
- R01 HL090136-04/HL/NHLBI NIH HHS/United States
- R01 CA140594/CA/NCI NIH HHS/United States
- P50 CA090578/CA/NCI NIH HHS/United States
- R01 HL090136/HL/NHLBI NIH HHS/United States
- K08 AG024004-01A1/AG/NIA NIH HHS/United States
- R01 CA122794-01/CA/NCI NIH HHS/United States
- NIH/NCI 2P50CA090578/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous